Business segment information (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule Of Net Sales by Reporting Segment

The table below presents net sales by reporting segment:

	Year Ended December 31,
	2018					2017					2016
(U.S. Dollars, in thousands)	Net Sales		Percent of Total Net Sales			Net Sales		Percent of Total Net Sales			Net Sales		Percent of Total Net Sales
Bone Growth Therapies	$	195,252		43.1	%	$	185,900		42.9	%	$	176,561		43.1	%
Spinal Implants		91,658		20.2	%		81,957		18.9	%		72,632		17.7	%
Biologics		59,684		13.2	%		62,724		14.4	%		57,912		14.1	%
Orthofix Extremities		106,448		23.5	%		103,242		23.8	%		102,683		25.1	%
Net sales	$	453,042		100.0	%	$	433,823		100.0	%	$	409,788		100.0	%

Summary of Non-GAAP Net Margin by Reporting Segment

The following table presents Non-GAAP net margin, and internal metric that the Company defines as gross profit less sales and marketing expense, by reporting segment:

	Year Ended December 31,
(U.S. Dollars, in thousands)	2018			2017			2016
Bone Growth Therapies	$	86,252		$	77,369		$	75,469
Spinal Implants		7,628			8,730			8,650
Biologics		26,298			25,692			26,891
Orthofix Extremities		31,391			31,071			30,526
Corporate		(682	)		(446	)		(888	)
Non-GAAP net margin	$	150,887		$	142,416		$	140,648
General and administrative		84,506			71,905			76,409
Research and development		33,218			29,700			28,803
Changes in fair value of contingent consideration		3,069			—			—
Charges related to U.S. Government resolutions		—			—			14,369
Operating income	$	30,094		$	40,811		$	21,067
Interest income (expense), net		(828	)		(416	)		763
Other expense, net		(6,381	)		(4,004	)		(2,806	)
Income before income taxes	$	22,885		$	36,391		$	19,024

Schedule of Depreciation and Amortization by Reporting Segment

The following table presents depreciation and amortization by reporting segment:

	Year Ended December 31,
(U.S. Dollars, in thousands)	2018		2017		2016
Bone Growth Therapies	$	1,770	$	2,133	$	2,754
Spinal Implants		7,294		6,949		8,118
Biologics		448		752		1,011
Orthofix Extremities		5,342		6,040		5,742
Corporate		3,805		4,250		3,216
Total	$	18,659	$	20,124	$	20,841

Summary of Net Sales by Geographic Destination

The following data includes net sales by geographic destination:

(U.S. Dollars, in thousands)	2018		2017		2016
U.S.	$	355,353	$	345,145	$	316,873
Italy		19,331		17,059		16,664
Germany		11,606		7,063		6,448
United Kingdom		8,731		8,725		10,362
Brazil		7,120		10,356		11,334
Others		50,901		45,475		48,107
Net sales	$	453,042	$	433,823	$	409,788

The table below presents net sales by geographic destination for each reporting segment and for the consolidated Company:

(U.S. Dollars, in thousands)	2018		2017		2016
Bone Growth Therapies
U.S.	$	195,189	$	185,853	$	176,510
International		63		47		51
Total Bone Growth Therapies		195,252		185,900		176,561
Spinal Implants
U.S.		72,137		69,704		57,772
International		19,521		12,253		14,860
Total Spinal Implants		91,658		81,957		72,632
Biologics
U.S.		59,668		62,670		57,574
International		16		54		338
Total Biologics		59,684		62,724		57,912
Orthofix Extremities
U.S.		28,359		26,918		25,017
International		78,089		76,324		77,666
Total Orthofix Extremities		106,448		103,242		102,683
Consolidated
U.S.		355,353		345,145		316,873
International		97,689		88,678		92,915
Net sales	$	453,042	$	433,823	$	409,788

Summary of Property, Plant and Equipment of Reporting Segments by Geographic Area

The following data includes property, plant and equipment by geographic area:

(U.S. Dollars, in thousands)	2018		2017
U.S.	$	31,344	$	34,008
Italy		7,732		7,658
Germany		861		933
United Kingdom		896		382
Brazil		191		475
Others		1,811		1,683
Total	$	42,835	$	45,139